This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated DGAT2 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-DGAT2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~43.8 kDa | |
| Gel | 12–15% (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | — | |
| Caveat | Membrane extraction controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 2 isoform(s) |
The A03174 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | C6 (40ug), AML-12 (40ug), A375 (40ug) (catalog A03174) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A03174; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
DGAT2 is predicted at 43.8 kDa; isoforms and multimeric complexes could affect bands, but their migration has not been demonstrated here.
| Band near 43.8 kDa | Consistent with the predicted DGAT2 mass; confirm identity with antibody controls |
| Bands at different sizes | Could reflect isoforms 1 and 2, whose migration has not been established |
| Higher-mass band | Could reflect retained complexes containing several DGAT2 subunits |
| Weak band in a soluble lysate fraction | Could reflect DGAT2 association with endoplasmic reticulum membranes and lipid droplets |
| UniProt predicted mass | Places the reference monomer near 43.8 kDa |
| Splice isoform 1 | May migrate differently from isoform 2; its mass is not supplied |
| Splice isoform 2 | May migrate differently from isoform 1; its mass is not supplied |
| Multimeric DGAT2 complexes | Could yield a higher apparent mass if complexes persist during electrophoresis |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Membrane-associated DGAT2 may be poorly recovered | Check membrane extraction and include a positive control lysate |
| Band higher than expected | DGAT2 complexes may persist, though their migration is unverified | Check denaturation and confirm identity with an independent antibody or DGAT2 depletion |
| Band lower than expected | An alternative isoform is possible, but its mass is unknown | Check isoform expression and confirm band identity with DGAT2 depletion |
| Multiple bands | Alternative isoforms or retained DGAT2 complexes are possible | Compare denaturing conditions and confirm bands with DGAT2 depletion |
| Weak or no signal | Membrane-associated DGAT2 may be underrepresented in the prepared fraction | Assess membrane protein recovery and use a positive control lysate |
| Fragments below expected size | DGAT2 may have degraded during sample preparation | Repeat with fresh lysate and protease inhibitors; verify fragment identity |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for DGAT2, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
The catalog reports one anti-DGAT2 antibody, A03174, with stated Human, Mouse, and Rat reactivity. Its WB image shows C6, AML-12, A375, L02, and HepG2 whole-cell lysates at 40 µg per lane using a 1:500 antibody dilution. Broader sample validation is not shown.
Which to pick: A03174 is the only listed option and has a WB image. Check its stated reactivity and pictured samples and conditions against your experiment; the image documents those five lysates only.